Humanin
HN / HNG / Humanin G
Humanin is a 24-amino acid mitochondrial-derived peptide (MDP) encoded within the 16S ribosomal RNA gene of mitochondrial DNA, first discovered in 2001 from surviving neurons in Alzheimer's disease brains. It exhibits potent neuroprotective, anti-apoptotic, and cytoprotective properties across multiple organ systems through interactions with IGFBP-3, BAX, and the formyl peptide receptor-like 1 (FPRL1). Research interest has expanded from neurodegeneration to encompass metabolic disease, cardiovascular protection, and aging biology.
作用機序
Mitochondria-derived micropeptide encoded in the 16S rRNA region. Neuroprotective through binding to IGFBP-3 (blocking apoptosis), activating STAT3 signaling, and modulating BAX-mediated cell death. Also improves insulin sensitivity and reduces amyloid-beta toxicity.
研究プロトコル
研究目的のみで使用。医療アドバイスではありません。
Research protocols are primarily preclinical. Humanin analogs (HNG, HNGF6A) used at 1-4mg/kg in animal models. Human dosing not established. Intranasal and subcutaneous routes studied.
研究ノート
Clinical Research Status
Humanin remains in the preclinical and early translational research phase, with no completed human clinical trials as of current literature. Observational studies have found that circulating humanin levels decline with age and correlate inversely with markers of cognitive decline and metabolic dysfunction. Several humanin analogs with enhanced potency and stability, particularly HNG (S14G-Humanin), have been developed to overcome the native peptide's short half-life and advance toward clinical testing.
Key Published Findings
The original discovery by Bhimori Hashimoto (2001) demonstrated that humanin specifically protected neurons against amyloid-beta toxicity, presenilin mutant-induced apoptosis, and other Alzheimer's-related insults. Subsequent research revealed humanin acts as an insulin sensitizer, reducing hepatic glucose production and improving glucose tolerance in animal models of diabetes. Studies in cardiovascular models show humanin protects against ischemia-reperfusion injury, reduces atherosclerotic plaque formation, and inhibits vascular smooth muscle cell apoptosis.
Safety Profile
As an endogenously produced peptide, humanin is considered to have a favorable safety profile, though systematic toxicology studies in humans have not been conducted. The primary theoretical concern involves its anti-apoptotic properties potentially interfering with tumor suppression mechanisms, though some evidence suggests it may actually enhance certain anti-cancer immune responses. No significant adverse effects have been reported in animal studies at supraphysiological doses, though long-term exposure data remains limited.
Comparison to Related Compounds
Humanin is the founding member of the mitochondrial-derived peptide family, which also includes MOTS-c (a 16-amino acid exercise mimetic peptide) and the SHLPs (Small Humanin-Like Peptides 1-6). Unlike exogenous neuroprotective peptides such as Cerebrolysin or Semax, humanin represents an endogenous protective signal that declines with mitochondrial aging. The analog HNG is approximately 1000-fold more potent than native humanin, making it more practical for research applications.
Community Observations
Interest in humanin within longevity research communities centers on its role as a biomarker and potential therapeutic for mitochondrial aging. Due to extremely limited commercial availability and the early stage of research, human experimentation outside academic settings is rare. The peptide's connection to centenarian genetics (elevated humanin levels correlate with exceptional longevity) has generated significant interest in the anti-aging research community.
半減期
~30-60 minutes
再構成
Sterile saline or bacteriostatic water
保存
乾燥粉末
Store at -20C. Sensitive to freeze-thaw cycles.
再溶解
Refrigerate 2-8C. Use within 7 days.
米国法的状況
また知られる名前
最新の研究
Highlight the role of humanin and MOTS-c in aging processes and their potential as therapeutic targets for age-related diseases.
Highlighting the emerging role of mitochondria-derived peptides (MDPs) in aging and disease could attract interest from researchers and clinicians interested in novel therapeutic targets.
よくある質問
Humaninとは何ですか?
Humanin is a 24-amino acid mitochondrial-derived peptide (MDP) encoded within the 16S ribosomal RNA gene of mitochondrial DNA, first discovered in 2001 from surviving neurons in Alzheimer's disease brains. It exhibits potent neuroprotective, anti-apoptotic, and cytoprotective properties across multiple organ systems through interactions with IGFBP-3, BAX, and the formyl peptide receptor-like 1 (FPRL1). Research interest has expanded from neurodegeneration to encompass metabolic disease, cardiovascular protection, and aging biology.
Humaninはどのように作用しますか?
Mitochondria-derived micropeptide encoded in the 16S rRNA region. Neuroprotective through binding to IGFBP-3 (blocking apoptosis), activating STAT3 signaling, and modulating BAX-mediated cell death. Also improves insulin sensitivity and reduces amyloid-beta toxicity.
Humaninの米国での規制状況は?
Research chemical (not FDA-approved)
Humaninの半減期は?
~30-60 minutes
Humaninの別名は?
HN, HNG, Humanin G
ペプチドコンタクトは、研究目的のみのための要約情報を提供しています。私たちはベンダーの文書をホスト、配布、または推奨していません。すべての分析証明書、GMP認定証明書、およびベンダーコミュニケーションは、購入者によって直接要求され、確認される必要があります。このプラットフォーム上の何らかの情報は法的、医学的、または専門的なアドバイスを構成していません。ユーザーは、適切な法律、州法、および連邦法に準拠するためにベンダー資格を検証し、購入前に遵守することに全責任を持つ必要があります。このプラットフォームを使用することで、完全な個人的責任を承認することになります。
完全な免責事項を読む